Product Information

AMLODIPINE-ATORVAST 10-10 MG is a generic product labeled by Prasco Laboratories, priced at $0.9964 per EA under NDC 66993027030. Its NADAC has been published 221 times since Jun 1, 2022.

FDA first approved this application on Jan 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 10-10 MG

Amlodipine and Atorvastatin
$0.9964per EA

Strength

10; 10 mg/1; mg/1

NDC

66993027030

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021540

FDA Approved

1/30/2004

TE Code

AB

On Market Since

3/14/2022

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 10-10 MG has been published 221 times since Jun 1, 2022, and over the history we have for it it has declined 37.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9964 per EA
All-time high$2.2541 (Aug 10, 2022)
All-time low$0.6894 (Jul 17, 2024)
52-week high$1.6115
52-week low$0.9964
Median price$1.2757
Average price$1.2982
Largest weekly change+65.6% (Feb 22, 2023)
Weeks tracked221
Tracking sinceJun 1, 2022

Price History

1W

-2.8%

1M

-2.8%

3M

-7.6%

6M

-22.1%

1Y

-25.0%

3Y

-48.5%

5Y

N/A

All

-37.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 10-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-10 MG, manufactured by Prasco Laboratories, is $0.9964 per EA (NDC 66993027030), effective Aug 19, 2026.

How has the price of AMLODIPINE-ATORVAST 10-10 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-10 MG has declined 37.3%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-10 MG?

Since Jun 1, 2022, the NADAC for AMLODIPINE-ATORVAST 10-10 MG has ranged from a low of $0.6894 (Jul 17, 2024) to a high of $2.2541 (Aug 10, 2022), with a median of $1.2757 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-10 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-10 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-ATORVAST 10-10 MG?

AMLODIPINE-ATORVAST 10-10 MG (NDC 66993027030) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.